Continue Reading Below
After a sell-off that's seen its shares drop from over $20 in July to below $13 earlier this month, news that a hedge fund has acquired a 5.7% stake sent shares of Tenet Healthcare (NYSE: THC) soaring 14.2% at 2:00 p.m. EDT today.
On Aug. 7, Tenet Healthcare reported second-quarter financial results that were anything but encouraging. In the quarter, the company's net revenue declined 1.4% to $4.8 billion, and its net loss expanded 19.6%, to $55 million, or $0.55 per share. On an adjusted basis, the company's net loss per share was $0.17. These figures were worse than investors were looking for, and shares were punished as a result.
Last week, two members of Tenet Healthcare's board of directors resigned, citing "irreconcilable differences." The two members are employees of Glenview Capital Management, a major Tenet Healthcare investor, and their departure triggers the expiration of a standstill agreement later this month. After the standstill agreement expires, Glenview can evaluate other options that could unlock shareholder value in the company, and according to Glenview's press release on that matter, they are committed to remaining a Tenet Healthcare investor. Perhaps this suggests that a proxy fight for control of the board is in the making. As of June 30, Glenview is Tenet Healthcare's largest shareholder, with holdings of 17.9 million shares.
Tenet Healthcare's shares moved up significantly after Glenview's announcement, and Camber Capital Management today revealed in a Securities and Exchange Commission filing that it's amassed a 5.7% position in Tenet Healthcare, adding conviction to the thinking that a management shake-up can unlock shareholder value. As of June 30, Camber Capital reported $1.4 billion in assets invested in 37 positions, including a 4 million share stake in Tenet Healthcare. Currently, Camber Capital owns 5.75 million shares.
Continue Reading Below
After its lackluster performance last quarter, Tenet Healthcare ratcheted back its outlook for the full year. In addition to its operating headwinds, Tenet Healthcare also faces uncertainty regarding the future of Obamacare. Because Obamacare has decreased the uninsured rate, it has had a positive impact on hospital write-offs that are associated with charity care that's provided to patients.
Clearly, Glenview and Camber Capital believe there's value in Tenet Healthcare that can be unlocked. However, it's unclear exactly how that might happen. Until we get greater insight into how Glenview will proceed, or see signs that Tenet Healthcare's business is improving, the volatility that's likely in this stock has me thinking there are better stocks for investors to focus on.
10 stocks we like better than Tenet Healthcare
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Tenet Healthcare wasn't one of them! That's right -- they think these 10 stocks are even better buys.
Click here to learn about these picks!
*Stock Advisor returns as of August 1, 2017
Todd Campbell has no position in any stocks mentioned. His clients may have positions in the companies mentioned.
The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.